IRD earnings date and last-quarter result: next report 2026-08-12, last quarter miss, P/E -2.33. Updated 2026-07-23.
Opus Genetics (IRD) Research Hub
Opus Genetics (IRD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.32 USD (-4.32%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.33, market cap 0.25B. This hub links to the full technical, earnings and options research available for IRD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.32 USD (-4.32%) |
| 52-week range | 2.82 USD – 7.07 USD |
| Trend regime | Range |
| 14-day RSI | 25.8 (Oversold) |
| Trailing P/E | -2.33 |
| Market cap | 0.25B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for IRD
Covered Call on IRD: how it works, illustrative setup around the real 3.32 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IRD: how it works, illustrative setup around the real 3.32 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IRD: how it works, illustrative setup around the real 3.32 USD price, max profit/loss, breakeven and when to use it. Educational.
IRD technical analysis: range, last 3.32 USD, RSI 25.8, 52w range 2.82 USD–7.07 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IRD in?
Opus Genetics (IRD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IRD in an uptrend or downtrend?
As of 2026-10-26, IRD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IRD's trailing P/E ratio?
IRD's trailing P/E is -2.33, with a market cap of 0.25B. See the earnings research page for full valuation detail.
When does IRD next report earnings?
IRD is next scheduled to report earnings on 2026-08-12.